« Oncodistinct is a non-profit research network bringing together academic lead investigators with expertise in clinical research in oncology. This network developed, is developing and aims to create innovative early to later phases clinical trials.»
Call for Applications Grant Application Template 🚀 Oncodistinct Biannual Grant – €20,000 To support academic clinical research within our network : Funding Amount: €20,000 Application Deadline: June 1,
When : Thursday 19 and Friday 20 June 2025
Where : The Bank of Cyprus Oncology Centre in Nicosia (Cyprus).
For more details, please send an e-mail to oncodistinct@hubruxelles.be
📢 Francesco Sclafani and Ali Shamseddine from the Oncodistinct Network, had the opportunity to present Oncodistinct trials (REGINA & AVERECTAL) at the last ESMO GI 2024 in Munich, Germany
Oncodistinct Network achieved important milestones for SHAPERS and COPERNIC studies
Jérémy Blanc presented survival data results from AURA trial: Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004) at ASCO 2024 in Chicago, USA
We are pleased to announce that the next Oncodistinct Meeting will take place on Thursday 17th & Friday 18th October 2024 at the Institut Paoli-Calmettes in Marseille, France. Please save the date !
ONCODISTINCT. Accelerating Oncology drug Development and Innovative strategies in Clinical Trials
© Oncodictinct 2024 – Privacy policy
